Medications for Multiple Myeloma

54 results

  • aphexda

    (Motixafortide)
    BioLineRx USA Inc
    APHEXDA is indicated, in combination with filgrastim (G-CSF), for mobilizing hematopoietic stem cells into peripheral blood for collection and autologous transplantation in patients with multiple myeloma.

  • bortezomib

    (Bortezomib)
    Novadoz Pharmaceuticals LLC
    Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.

  • bortezomib

    (Bortezomib)
    Accord Healthcare Inc.
    Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.

  • bortezomib

    (BORTEZOMIB)
    Hospira, Inc.
    Bortezomib for Injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.

  • bortezomib

    (bortezomib)
    Hikma Pharmaceuticals USA Inc.
    Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.

  • bortezomib

    (Bortezomib)
    NorthStar RxLLC
    Bortezomib for injection is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.

  • boruzu

    (Bortezomib)
    Amneal Pharmaceuticals LLC
    BORUZU is indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma.

  • carmustine

    (CARMUSTINE)
    Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
    Carmustine for Injection, USP is indicated for palliative therapy as a single agent or in combination therapy for brain tumors (e.g., glioblastoma), multiple myeloma (with prednisone), and relapsed or refractory Hodgkin's and Non-Hodgkin's lymphomas (with other approved drugs).

  • carmustine

    (CARMUSTINE)
    Sandoz Inc.
    Carmustine for injection is indicated for palliative therapy as a single agent or in combination for brain tumors, multiple myeloma (with prednisone), and relapsed or refractory Hodgkin's and Non-Hodgkin's lymphomas (with other approved drugs).

  • carmustine

    (CARMUSTINE)
    Accord Healthcare Inc.
    Carmustine for Injection is indicated for palliative therapy in brain tumors (e.g., glioblastoma), multiple myeloma (with prednisone), and relapsed or refractory Hodgkin's and Non-Hodgkin's lymphomas (in combination with other approved drugs).